Hydrogen sulfide and asthma

Experimental Physiology

Volumn 96, Issue 9, 2011, Pages 847-852

  Wang, Peipei ^a   Zhang, Gensheng ^a   Wondimu, Taddese ^a   Ross, Brian ^a   Wang, Rui ^a  

^a LAKEHEAD UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CYSTATHIONINE BETA SYNTHASE; CYSTATHIONINE GAMMA LYASE; HYDROGEN SULFIDE; INTERLEUKIN 5; MEPOLIZUMAB; NITRIC OXIDE; OVALBUMIN; REACTIVE OXYGEN METABOLITE;

AIR SAMPLING; AIRWAY REMODELING; ASTHMA; BRONCHOSPASM; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL MEMBRANE; CORTICOSTEROID THERAPY; FORCED EXPIRATORY VOLUME; HUMAN; HYPERPOLARIZATION; LUNG ALVEOLUS WALL; LUNG FUNCTION; MITOCHONDRIAL MEMBRANE; NONHUMAN; NOSE AIRFLOW; NOTE; OXIDATIVE STRESS; PATHOGENESIS; PEAK EXPIRATORY FLOW; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SMOOTH MUSCLE RELAXATION; TH2 CELL;

EID: 80051946338     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2011.057448     Document Type: Note

References (37)

1. Bara I, Ozier A, Tunon de Lara JM, Marthan R & Berger P (2010). Pathophysiology of bronchial smooth muscle remodelling in asthma. Eur Respir J 36, 1174-1184.
2. Barnes PJ (2006). New therapies for asthma. Trends Mol Med 12, 515-520.
3. Barnes PJ (2010). New therapies for asthma: is there any progress? Trends Pharmacol Sci 31, 335-343.
4. Baskar R, Li L & Moore PK (2007). Hydrogen sulfide-induces DNA damage and changes in apoptotic gene expression in human lung fibroblast cells. FASEB J 21, 247-255.
5. Cao W & Duan Y (2006). Breath analysis: potential for clinical diagnosis and exposure assessment. Clin Chem 52, 800-811.
6. Chen YH, Wang PP, Wang XM, He YJ, Yao WZ, Qi YF & Tang CS (2011). Involvement of endogenous hydrogen sulfide in cigarette smoke-induced changes in airway responsiveness and inflammation of rat lung. Cytokine 53, 334-341.
7. Chen YH, Wu R, Geng B, Qi YF, Wang PP, Yao WZ & Tang CS (2009a). Endogenous hydrogen sulfide reduces airway inflammation and remodeling in a rat model of asthma. Cytokine 45, 117-123.
8. Chen YH, Yao WZ, Gao JZ, Geng B, Wang PP & Tang CS (2009b). Serum hydrogen sulfide as a novel marker predicting bacterial involvement in patients with community-acquired lower respiratory tract infections. Respirology 14, 746-752.
9. Dombkowski RA, Russell MJ & Olson KR (2004). Hydrogen sulfide as an endogenous regulator of vascular smooth muscle tone in trout. Am J Physiol Regul Integr Comp Physiol 286, R678-R685.
10. Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, Jiao X, Scalia R, Kiss L, Szabo C, Kimura H, Chow CW & Lefer DJ (2007). Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 104, 15560-15565.
11. Flood-Page P, Swenson C, Faiferman I, Matthews J, Williams M, Brannick L, Robinson D, Wenzel S, Busse W, Hansel TT & Barnes NC (2007). A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Am J Respir Crit Care Med 176, 1062-1071.
12. Furne J, Saeed A & Levitt MD (2008). Whole tissue hydrogen sulfide concentrations are orders of magnitude lower than presently accepted values. Am J Physiol Regul Integr Comp Physiol 295, R1479-R1485.
13. Global Initiative for Asthma (GINA) (2010). Global Strategy for Asthma Management and Prevention. Available at: Accessed 27 June 2011.
14. 10 supplementation reduces corticosteroids dosage in patients with bronchial asthma. Biofactors 25, 235-240.
15. Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A, Marshall RP, Bradding P, Green RH, Wardlaw AJ & Pavord ID (2009). Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 360, 973-984.
16. Hu LF, Lu M, Wu ZY, Wong PT & Bian JS (2009). Hydrogen sulphide inhibits rotenone-induced apoptosis via preservation of mitochondrial function. Mol Pharmacol 75, 27-34.
17. Insko MA, Deckwerth TL, Hill P, Toombs CF & Szabo C (2009). Detection of exhaled hydrogen sulphide gas in rats exposed to intravenous sodium sulphide. Br J Pharmacol 157, 944-951.
18. Kharitonov SA & Barnes PJ (2006). Exhaled biomarkers. Chest 130, 1541-1546.
19. Kim HY, DeKruyff RH & Umetsu DT (2010).The many paths to asthma: phenotype shaped by innate and adaptive immunity. Nat Immunol 11, 577-584.
20. Kostikas K, Koutsokera A, Papiris S, Gourgoulianis KI & Loukides S (2008). Exhaled breath condensate in patients with asthma: implications for application in clinical practice. Clin Exp Allergy 38, 557-565.
21. Lesko LJ & Atkinson AJ Jr (2001). Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies. Annu Rev Pharmacol Toxicol 41, 347-366.
22. Mabalirajan U, Aich J, Leishangthem GD, Sharma SK, Dinda AK & Ghosh B (2009). Effects of vitamin E on mitochondrial dysfunction and asthma features in an experimental allergic murine model. J Appl Physiol 107, 1285-1292.
23. Miekisch W & Schubert JK (2006). From highly sophisticated analytical techniques to life-saving diagnostics: technical developments in breath analysis. Trends Anal Chem 25, 665-673.
24. Nagahara N, Ito T, Kitamura H & Nishino T (1998). Tissue and subcellular distribution of mercaptopyruvate sulfurtransferase in the rat: confocal laser fluroscence and immunoelectron microscopic studies combined with biochemical analysis. Histochem Cell Biol 110, 243-50.
25. Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E, Hargreave FE & O'Byrne PM (2009). Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 360, 985-993.
26. Olson KR, Whitfield NL, Bearden SE, St Leger J, Nilson E, Gao Y & Madden JA (2010). Hypoxic pulmonary vasodilation: a paradigm shift with a hydrogen sulfide mechanism. Am J Physiol Regul Integr Comp Physiol 298, R51-R60.
27. Perry MM, Hui CK, Whiteman M, Wood ME, Adcock I, Kirkham P, Michaeloudes C & Chung KF (2011). hydrogen sulfide inhibits proliferation and release of IL-8 from human airway smooth muscle cells. Am J Respir Cell Mol Biol; DOI:
28. Reddy PH (2011). Mitochondrial dysfunction and oxidative stress in asthma: implications for mitochondria-targeted antioxidant therapeutics. Pharmaceuticals (Basel) 4, 429-456.
29. Rodríguez-Fernández J, Pereiro R & Sanz-Medel A (2002).Optical fibre sensor for hydrogen sulphide monitoring in mouth air. Anal Chim Acta 471, 13-23.
30. Ross BM (2008). Sub-parts per billion detection of trace volatile chemicals in human breath using selected ion flow tube mass spectrometry. BMC Res Notes 1, 41.
31. i regulation in airway smooth muscle. FASEB J Meeting Abstract Supplement 622, 5.
32. Shaji J & Jadhav D (2010). Breath biomarker for clinical diagnosis and different analysis technique. Res J Pharma Biol Chem Sci 1, 639-353.
33. Snel J, Burgering M, Smit B, Noordman W, Tangerman A, Winkel EG & Kleerebezem M (2011). Volatile sulphur compounds in morning breath of human volunteers. Arch Oral Biol 56, 29-34.
34. Tangerman A & Winkel EG (2008). The portable gas chromatograph OralChroma™: a method of choice to detect oral and extra-oral halitosis. J. Breath Res 2, 017010.
35. 2S be the third endogenous gaseous transmitter? FASEB J 16, 1792-1798.
36. Wang R (2011). Signaling pathways for the vascular effects of hydrogen sulfide. Curr Opin Nephrol Hypertens 20, 107-112.
37. Wu R, Yao WZ, Chen YH, Geng B & Tang CS (2008). Plasma level of endogenous hydrogen sulfide in patients with acute asthma. Beijing Da Xue Xue Bao 40, 505-508.